Cargando…
A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023
A community cluster of influenza A(H3N2) caused by viruses with an E199G substitution in PA was detected in Nara, Japan, between February and March 2023. The three patients with these mutant viruses had not received antiviral treatment before specimen collection but patients in the same hospital had...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540515/ https://www.ncbi.nlm.nih.gov/pubmed/37768560 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.39.2300501 |
_version_ | 1785113736143437824 |
---|---|
author | Takashita, Emi Fujisaki, Seiichiro Morita, Hiroko Nagata, Shiho Miura, Hideka Matsuura, Yuki Yamamoto, Saya Chiba, Shoko Inoue, Yumiko Minami, Iori Yoshikawa, Sayaka Yamazaki, Seiko Kishida, Noriko Nakamura, Kazuya Shirakura, Masayuki Watanabe, Shinji Hasegawa, Hideki |
author_facet | Takashita, Emi Fujisaki, Seiichiro Morita, Hiroko Nagata, Shiho Miura, Hideka Matsuura, Yuki Yamamoto, Saya Chiba, Shoko Inoue, Yumiko Minami, Iori Yoshikawa, Sayaka Yamazaki, Seiko Kishida, Noriko Nakamura, Kazuya Shirakura, Masayuki Watanabe, Shinji Hasegawa, Hideki |
author_sort | Takashita, Emi |
collection | PubMed |
description | A community cluster of influenza A(H3N2) caused by viruses with an E199G substitution in PA was detected in Nara, Japan, between February and March 2023. The three patients with these mutant viruses had not received antiviral treatment before specimen collection but patients in the same hospital had. The sequences of the mutant viruses were closely related, suggesting clonal spread in Nara. They showed reduced susceptibility to baloxavir in vitro; however, the clinical significance of the PA E199G substitution remains unclear. |
format | Online Article Text |
id | pubmed-10540515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-105405152023-09-30 A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023 Takashita, Emi Fujisaki, Seiichiro Morita, Hiroko Nagata, Shiho Miura, Hideka Matsuura, Yuki Yamamoto, Saya Chiba, Shoko Inoue, Yumiko Minami, Iori Yoshikawa, Sayaka Yamazaki, Seiko Kishida, Noriko Nakamura, Kazuya Shirakura, Masayuki Watanabe, Shinji Hasegawa, Hideki Euro Surveill Rapid Communication A community cluster of influenza A(H3N2) caused by viruses with an E199G substitution in PA was detected in Nara, Japan, between February and March 2023. The three patients with these mutant viruses had not received antiviral treatment before specimen collection but patients in the same hospital had. The sequences of the mutant viruses were closely related, suggesting clonal spread in Nara. They showed reduced susceptibility to baloxavir in vitro; however, the clinical significance of the PA E199G substitution remains unclear. European Centre for Disease Prevention and Control (ECDC) 2023-09-28 /pmc/articles/PMC10540515/ /pubmed/37768560 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.39.2300501 Text en This article is copyright of the authors or their affiliated institutions, 2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Rapid Communication Takashita, Emi Fujisaki, Seiichiro Morita, Hiroko Nagata, Shiho Miura, Hideka Matsuura, Yuki Yamamoto, Saya Chiba, Shoko Inoue, Yumiko Minami, Iori Yoshikawa, Sayaka Yamazaki, Seiko Kishida, Noriko Nakamura, Kazuya Shirakura, Masayuki Watanabe, Shinji Hasegawa, Hideki A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023 |
title | A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023 |
title_full | A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023 |
title_fullStr | A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023 |
title_full_unstemmed | A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023 |
title_short | A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023 |
title_sort | community cluster of influenza a(h3n2) virus infection with reduced susceptibility to baloxavir due to a pa e199g substitution in japan, february to march 2023 |
topic | Rapid Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540515/ https://www.ncbi.nlm.nih.gov/pubmed/37768560 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.39.2300501 |
work_keys_str_mv | AT takashitaemi acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT fujisakiseiichiro acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT moritahiroko acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT nagatashiho acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT miurahideka acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT matsuurayuki acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT yamamotosaya acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT chibashoko acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT inoueyumiko acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT minamiiori acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT yoshikawasayaka acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT yamazakiseiko acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT kishidanoriko acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT nakamurakazuya acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT shirakuramasayuki acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT watanabeshinji acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT hasegawahideki acommunityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT takashitaemi communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT fujisakiseiichiro communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT moritahiroko communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT nagatashiho communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT miurahideka communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT matsuurayuki communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT yamamotosaya communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT chibashoko communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT inoueyumiko communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT minamiiori communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT yoshikawasayaka communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT yamazakiseiko communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT kishidanoriko communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT nakamurakazuya communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT shirakuramasayuki communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT watanabeshinji communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 AT hasegawahideki communityclusterofinfluenzaah3n2virusinfectionwithreducedsusceptibilitytobaloxavirduetoapae199gsubstitutioninjapanfebruarytomarch2023 |